Home > Healthcare > Medical Devices > Infection Control > Personal Protective Equipment for Infection Control Market
Personal Protective Equipment for Infection Control Market Analysis
- Report ID: GMI4625
- Published Date: Jan 2023
- Report Format: PDF
Personal Protective Equipment for Infection Control Market Analysis
Personal protective equipment for infection control market size from the face protection equipment product segment crossed USD 8.5 billion by 2032. The rising export of respiratory supplies to nations with fragile economic and medical systems will drive face mask production. In January 2022, the export of therapeutic respiration equipment including face masks from China to North Korea gained momentum, with trade valued at USD 2,769. Additionally, the capability to limit infections due to airborne bacteria, dust, and other pathogens will stimulate overall product consumption.
Based on usability, the reusable segment accounted for over 23% share of the personal protective equipment for infection control market in 2022, considering the product’s high sustainability and affordability. The increasing awareness about the generation of single-use gown waste and its contribution to the medical waste disposal issue has grown, resulting in a shift toward reusable counterparts. Since waste management has become a major concern for healthcare facilities, the adoption of reusable personal protective equipment in hospitals is expected to rise considerably in the upcoming years.
Personal protective equipment for infection control market from the research and diagnostic laboratories segment will reach over USD 5 billion by 2032, given the increase in clinical research funding. For instance, in November 2022, Tennessee-based Oak Ridge National Laboratory received funding worth USD 497 million under the Inflation Reduction Act signed into law in August. This funding was intended for scientific research and other programs, thus bolstering the usage of PPE to reduce infections. Furthermore, the need to improve infectious disease diagnosis will bolster the use of personal protective equipment for infection control in research and diagnostic labs.
Europe personal protective equipment for infection control market size is expected to be worth over USD 6 billion by 2032, on account of the increasing incidence of infectious diseases. This growing burden of infectious diseases and the escalating R&D efforts toward the development of advanced treatments will amplify the production of PPE for infection control across the region.
Frequently Asked Questions (FAQ) :
Personal Protective Equipment for Infection Control Market Scope
